2005 Edition Report on Drug Administration Procedure & Practices ...

More documents

Recommendations

Info

Hospital Authority Medication Incident <strong>Report</strong>ing Progamme (MIRP)8. With more than 1 1 / 2 years’ period of discussion since the idea was first recommended bythe Working Party on Drug Administration Procedure and Practices, and positivedevelopments in a number of HA Hospitals, it is time for an overall Medication Incident<strong>Report</strong>ing Programme (MIRP) to be set up for the Hospital Authority. The MIRP willcomprise the local <strong>Report</strong>ing Programme at each HA Institution and an overall monitoringand supporting function at the HAHO. Hospitals which already have a MIRP set up alongthe lines described below would continue to operate the programme whilst all otherHospitals are requested to set up their MIRP by 1 April 1994. The mode of operations ofthe MIRP are set out as follows:(a)(b)(c)(d)(e)(f)(g)(h)(i)Hospital staff are required to report all Medication Incidents (MI) irrespective ofwhether patients have been involved.Any staff coming to knowledge of a Medication Incident (MI) could report. Inparticular, managers responsible for operational units e.g. COS, DOM, WM, DM,should report.The reports are to be made on a standard proforma. A sample of such proforma isat Appendix I. Hospitals already with MIRP could retain their forms and otherhospitals could adapt the sample form at Appendix I for their own use.The identity of the staff involved in the Incident and the patient are NOTREQUIRED to be reported.The incidents reports are to be directed to the Hospital Drug Committee orequivalent mechanism. A panel consisting of at least one doctor, one pharmacistand one nurse will be appointed by the Hospital Drug Committee to review allreported cases in conjunction with the respective managers on a periodic basis.The Hospital Drug Committee will identify the underlying causes of each incidentand recommend appropriate preventive on remedial measures to the HCE.Hospital Drug Committee will also report the statistical data and anyrecommended action to the HAHO using the proforma at Appendix II.Documents related to these quality assurance activities are to be separately andsecurely filed by the Committee. This include the incidents reports which shouldNOT be filed into the patients medical record.These quality assurance related procedures should not interfere with any necessarycorrective and supportive therapy to the patient.Medication errors resulting in injury to the patient should be reported to theHAHO Legal Liaison Officer in parallel and handled separately according to HAGeneral Admin Circular No 2/92.Continuous Review and Follow-up action9. Whilst Hospitals will take appropriate remedial / preventive actions regarding problemsunveiled by reviewing medication incidents occurring locally, HAHO would monitor theoverall trend of medication incidents and consider appropriate global measures againstmajor or service wide problems and to support the Hospitals in this area.[Appendix I & II are not included] HAHO Feb 942
Appendix 16Adverse Drug Reaction <strong>Report</strong>ing Programme
Page 2 and 3:
ForewordMedication safety and provi
Page 4 and 5:
Chapter 6 summarizes the specific r
Page 6 and 7:
Chapter 6Conclusions and Recommenda
Page 8 and 9:
CHAPTER ONETHE WORKING GROUPMEMBERS
Page 10 and 11:
CHAPTER TWOTHE PROGRESS REPORT2.1 P
Page 12 and 13:
CHAPTER THREEAREAS FOR IMPROVEMENT
Page 14 and 15:
Existing In-patient Drug Administra
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
CHAPTER FOURRECOMMENDED PRACTICES A
Page 24 and 25:
Drug Name4.11 There should be a hos
Page 26 and 27:
Electronic prescribing (Medication
Page 28 and 29:
4.46 When the use of CM is permitte
Page 30 and 31:
cytotoxic and central intravenous a
Page 32 and 33:
4.72 Special precautions should be
Page 34 and 35:
4.84 To prevent mixing up medicatio
Page 36 and 37:
The Principle of Three checks and F
Page 38 and 39:
4.111 Three-way (red and blue) and
Page 40 and 41:
or their discharge or death, should
Page 42 and 43:
operational requirement but also it
Page 44 and 45:
Quality Complaints on Pharmaceutica
Page 46 and 47:
LEVELSHAHOCE / DTOOLS & MECHANISMDU
Page 48 and 49:
Medication Incident Report<
Page 50 and 51: Continuing Education6.18 In order t
Page 52 and 53: APPENDICESAppendix 1Appendix 2Appen
Page 54 and 55: Hospital Authority Hospital No. : I
Page 56 and 57: Sensitivity:Prescription/ routewith
Page 58 and 59: Appendix 3aLists of HA-wide Approve
Page 60 and 61: DRUGTeniposideABBREVIATIONVM-26Thia
Page 62 and 63: Appendix 3b“Do Not Use Abbreviati
Page 64 and 65: Appendix 4Schedule for the Administ
Page 66 and 67: Appendix 5Mechanism for the Managem
Page 68 and 69: 4. As with all medications, there s
Page 70 and 71: Appendix 6HA Guideline on Safe Mana
Page 72 and 73: 2.1 Concentrated potassium chloride
Page 74 and 75: Appendix 7Supply of Antidotes and D
Page 76 and 77: 複本 Antidotes and emeg drug lis
Page 78 and 79: Appendix 8Guidelines for Supply of
Page 80 and 81: substitution with other drugs in ac
Page 82 and 83: Appendix 9Samples of the Line Label
Page 84 and 85: Appendix 10Guidelines on the use of
Page 86 and 87: Appendix 11Guidelines on Patient Se
Page 88 and 89: Operational Guidelines7. The operat
Page 90 and 91: COC(N) Paper 12/2004Approved by COC
Page 92 and 93: 7.4 Evaluation Record and report th
Page 94 and 95: DISPOSAL OF HOSPITAL PHARMACEUTICAL
Page 96 and 97: Appendix 14Guidelines on the Handli
Page 98 and 99: Appendix 15Medication Incident <str
Page 102 and 103: QUALITY ASSURANCE IN DRUG THERAPYHO
Page 104 and 105: Fig. 1: ADR voluntary reporting sys
Page 106 and 107: PROCEUDRE FOR QUALITY COMPLAINTSONP
Page 108: Part II Procurement Section, CPO1.
show all

2005 Edition Report on Drug Administration Procedure & Practices ...

Create successful ePaper yourself

Delete template?

Save as template?